Cargando…

Correlation between BDNF levels and folic acid levels at baseline in drug-naïve First Episode Psychosis

INTRODUCTION: Schizophrenia is a severe and common psychiatric disorder characterized by disturbed brain development. Brain-derived neurotrophic factor (BDNF) mediates differentiation and survival of neurons as well as synaptic plasticity during the brain development. Several studies have shown decr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Toll, A., Bergé, D., Canosa, I., Martín - Subero, M., Legido, T., Fernandez - Hinchado, C., Perez - Sola, V., Mané, A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2023
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10392997/ http://dx.doi.org/10.1192/j.eurpsy.2023.442

Ejemplares similares

Multidimensional predictors of negative symptoms in antipsychotic-naive first-episode psychosis
por: Toll, Alba, et al.
Publicado: (2022)

Association between lymphocytes, hippocampus volume and depressive symptoms in drug – naïve First Episode Psychosis
por: Toll, A., et al.
Publicado: (2022)

Distinctive features of First Episode of Psychosis during the Covid-19 pandemic
por: Casanovas, F., et al.
Publicado: (2022)

Method of levels therapy for first-episode psychosis: rationale, design and baseline data for the feasibility randomised controlled Next Level study
por: Griffiths, Robert, et al.
Publicado: (2018)

Network-Level Dysconnectivity in Drug-Naïve First-Episode Psychosis: Dissociating Transdiagnostic and Diagnosis-Specific Alterations
por: Gong, Qiyong, et al.
Publicado: (2017)

Dehydroepiandrosterone sulfate (DEHA-S), cortisol and adrenocorticotropic hormone (ACTH) levels in drug-naive, first episode patients with psychosis
por: Petrikis, P., et al.
Publicado: (2021)

The month of walking alone and BDNF level differ between drug-naive first-episode schizophrenia patients and healthy controls
por: Zhang, Zhenmei, et al.
Publicado: (2023)

BDNF, proBDNF and IGF-1 serum levels in naïve and medicated subjects with autism
por: Robinson-Agramonte, Maria de los Angeles, et al.
Publicado: (2022)

Hair cortisol in drug-naïve first-episode individuals with psychosis
por: Andrade, Elvis H., et al.
Publicado: (2016)

Dehydroepiandrosterone Sulfate, Cortisol and Adrenocorticotropic Hormone Levels in Drug-Naive, First Episode, Male and Female Patients With Psychosis
por: Christou, Maria, et al.
Publicado: (2021)

Treatment response after 6 and 26 weeks is related to baseline glutamate and GABA levels in antipsychotic-naïve patients with psychosis
por: Bojesen, Kirsten B., et al.
Publicado: (2020)

Serum proBDNF/BDNF and response to fluvoxamine in drug-naïve first-episode major depressive disorder patients
por: Yoshimura, Reiji, et al.
Publicado: (2014)

Study on correlations of BDNF, PI3K, AKT and CREB levels with depressive emotion and impulsive behaviors in drug-naïve patients with first-episode schizophrenia
por: Li, Shan, et al.
Publicado: (2023)

Serum Levels of High Sensitivity C-reactive Protein in Drug-naïve First-episode Psychosis and Acute Exacerbation of Schizophrenia
por: Bolu, Abdullah, et al.
Publicado: (2019)

Effects of Risperidone on Cytokine Profile in Drug-Naïve First-Episode Psychosis
por: Noto, Cristiano, et al.
Publicado: (2015)

Genetic polymorphisms of BDNF on cognitive functions in drug-naive first episode patients with schizophrenia
por: Su, Xiuru, et al.
Publicado: (2021)

Lower Vitamin C Levels Are Associated With Less Improvement in Negative Symptoms in Initially Antipsychotic-Naïve Patients With First-Episode Psychosis
por: Myken, Anders N, et al.
Publicado: (2022)

The effect of early life events on glucose levels in first-episode psychosis
por: Garcia-Rizo, Clemente, et al.
Publicado: (2022)

Incidence rate and distinctive characteristics of first episode psychosis during the COVID-19 pandemic: a multicenter observational study
por: Casanovas, Francesc, et al.
Publicado: (2022)

Hippocampal glutamate and hippocampus subfield volumes in antipsychotic-naive first episode psychosis subjects and relationships to duration of untreated psychosis
por: Briend, Frédéric, et al.
Publicado: (2020)

Abnormal reward prediction-error signalling in antipsychotic naive individuals with first-episode psychosis or clinical risk for psychosis
por: Ermakova, Anna O., et al.
Publicado: (2018)

Schneider’s first-rank symptoms as predictors of remission in antipsychotic-naive first-episode psychosis
por: Malinowski, Fernando R., et al.
Publicado: (2019)

The association between BDNF levels and risperidone-induced weight gain is dependent on the BDNF Val66Met polymorphism in antipsychotic-naive first episode schizophrenia patients: a 12-week prospective study
por: Liu, Jiahong, et al.
Publicado: (2021)

A Study of Soft Neurological Signs and Its Correlates in Drug-Naive Patients with First Episode Psychosis
por: Gunasekaran, Vanishree, et al.
Publicado: (2016)

Neurometabolic correlates of 6 and 16 weeks of treatment with risperidone in medication-naive first-episode psychosis patients
por: Birur, Badari, et al.
Publicado: (2020)

T135. NEIGHBORHOOD-LEVEL PREDICTORS OF AGE AT ONSET AND DURATION OF UNTREATED PSYCHOSIS IN FIRST-EPISODE PSYCHOSIS
por: Ku, Benson, et al.
Publicado: (2018)

T165. ULTRA-HIGH FIELD MORPHOMETRY IN DRUG-NAïVE FIRST EPISODE PSYCHOSIS
por: Das, Tushar, et al.
Publicado: (2018)

Hyperprolactinemia and insulin resistance in drug naive patients with early onset first episode psychosis
por: Petruzzelli, Maria Giuseppina, et al.
Publicado: (2018)

D1-Dopamine Receptor Availability in First-Episode Neuroleptic Naive Psychosis Patients
por: Stenkrona, Per, et al.
Publicado: (2019)

EEG Microstate Differences in Medicated vs. Medication-Naïve First-Episode Psychosis Patients
por: Mackintosh, Amatya J., et al.
Publicado: (2020)

Macroscale EEG characteristics in antipsychotic-naïve patients with first-episode psychosis and healthy controls
por: Dominicus, L. S., et al.
Publicado: (2023)

White Matter Integrity, Duration of Untreated Psychosis, and Antipsychotic Treatment Response in Medication-Naïve First Episode Psychosis Patients
por: Kraguljac, Nina Vanessa, et al.
Publicado: (2020)

The effect of excess weight on circulating inflammatory cytokines in drug-naïve first-episode psychosis individuals
por: Juncal-Ruiz, María, et al.
Publicado: (2018)

Insulin resistance in first episode antipsychotic naïve psychosis patients-A cross sectional study.
por: Akshatha, C J, et al.
Publicado: (2022)

Resting-state brain functional alterations and their genetic mechanisms in drug-naive first-episode psychosis
por: Li, Qian, et al.
Publicado: (2023)

T14. HYPOTHALAMIC-PITUITARY-GONADAL AXIS HORMONES IN ANTIPSYCHOTIC NAïVE FIRST-EPISODE OF PSYCHOSIS AND HEALTHY CONTROLS
por: Teresa Pons-Cabrera, Maria, et al.
Publicado: (2020)

Cholesterol and triglyceride levels in first-episode psychosis: systematic review and meta-analysis
por: Pillinger, Toby, et al.
Publicado: (2017)

In Vivo Availability of Cannabinoid 1 Receptor Levels in Patients With First-Episode Psychosis
por: Borgan, Faith, et al.
Publicado: (2019)

A Meta-Analysis of the Influence of Antipsychotics on Cytokines Levels in First Episode Psychosis
por: Marcinowicz, Piotr, et al.
Publicado: (2021)

S19. EVIDENCE OF THE LIPID PARADOX IN PSYCHOSIS: A META-ANALYSIS OF CHOLESTEROL AND TRIGLYCERIDE LEVELS IN FIRST EPISODE PSYCHOSIS
por: Pillinger, Toby, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_jk2fbd3bsk3ddc418jlugc32nq